
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1029 | 972 | 1010 | 1288 | 1810 | 2107 |
Fund Return | 2.87% | -2.81% | 1% | 8.81% | 12.59% | 7.74% |
Place in category | 116 | 95 | 103 | 5 | 3 | 31 |
% in Category | 66 | 50 | 58 | 4 | 1 | 28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Prudential Jennison Growth Z | 3.84B | 0.01 | 14.44 | 15.39 | ||
Prudential Jennison Global Opps Z | 2.75B | -1.27 | 8.44 | 13.38 | ||
Prudential Jennison Utility A | 2.68B | 3.21 | 9.61 | 8.48 | ||
Prudential Jennison Small Company Q | 1.91B | -2.89 | 3.16 | 9.04 | ||
Prudential Jennison Growth A | 1.79B | -0.03 | 14.09 | 15.04 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 34.63B | 4.15 | 4.94 | 7.02 | ||
Fidelity Select Health Care | 10.35B | 2.50 | 3.68 | 7.60 | ||
T. Rowe Price Health Sciences | 7.28B | 4.25 | 3.25 | 8.01 | ||
Vanguard Health Care Inv | 6.25B | 4.15 | 4.89 | 6.97 | ||
Fidelity Advisor Health Care A | 6.23B | 2.55 | 3.18 | 6.79 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 15.09 | 825.91 | +0.41% | |
UnitedHealth | US91324P1021 | 4.76 | 523.75 | +1.49% | |
Vertex | US92532F1003 | 4.45 | 484.82 | -1.60% | |
Abbott Labs | US0028241000 | 4.44 | 132.65 | +1.40% | |
argenx ADR | US04016X1019 | 4.37 | 592.31 | +0.54% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review